Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1234.60
-10.90 (-0.88%) Dr. Reddy's Laboratories informs about press release
Date: 04-09-2021Dr. Reddy's Laboratories has informed that it enclosed a Press Release on 4th September titled ‘Dr. Reddy's Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)’.
The above information is a part of company’s filings submitted to BSE.